R&D

Dry powder inhalers of conjugated linoleic acid for the treatment of primary lung cancer

Source：Acta Pharmaceutica SinicaAuthor：ZHANG Guo-li , XIAO Zhi-mei Date：2026-06-12

1781252707250349.png

1781252755859662.png

1781252815823425.png

1781252906438256.png

1781252972392325.png

1781253169590155.png

1781253770321930.png1781253836763924.png1781253912342101.png1781253971185007.png1781254009988999.png

1781254065643130.png1781254161684509.png

1781254209551839.png

Download

Dry powder inhalers of conjugated linoleic acid for the treatment of primary lung cancer.pdf

Prev： Ｒ Language Assisted Excipient Compatibility and Formulation Optimization of Epirubicin Tablets

Next： Global status report on alcohol and health and treatment of substance use disorders

Back

You May Like：

Tel：0086 755 84208896

Addr：Changfang Lighting Industrial Factory Building C2-101, Zhukeng Community, Longtian Street, Pingshan District, Shenzhen China

Follow Us


Scan the code to follow Shankang!

Copyright © 2025-2026 Shenzhen Shankang Pharmaceutical Technology Co., Ltd 粤ICP备20040229号-1